HBK Investments’s Insmed INSM Stock Holding History

HBK Investments’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,300	Closed	-$291K	–	1257
2018 Q2	$291K	Sell	12,300 -85,952	-87%	-$2.21M	﹤0.01%	910
2018 Q1	$2.21M	Buy	98,252 +51,977	+112%	+$1.37M	0.02%	428
2017 Q4	$1.44M	Sell	46,275 -46,140	-50%	-$1.36M	0.01%	534
2017 Q3	$2.88M	Buy	92,415 +61,315	+197%	+$1.17M	0.02%	373
2017 Q2	$534K	Buy	+31,100	New	+$531K	﹤0.01%	707
2016 Q1	–	Sell	-12,500	Closed	-$227K	–	1037
2015 Q4	$227K	Sell	12,500 -53,403	-81%	-$941K	﹤0.01%	903
2015 Q3	$1.22M	Buy	65,903 +56,803	+624%	+$1.42M	0.01%	540
2015 Q2	$222K	Buy	+9,100	New	+$207K	﹤0.01%	870
2014 Q4	–	Sell	-69,502	Closed	-$907K	–	1050
2014 Q3	$907K	Sell	69,502 -31,921	-31%	-$481K	0.01%	578
2014 Q2	$2.03M	Buy	101,423 +46,723	+85%	+$692K	0.04%	341
2014 Q1	$1.04M	Buy	+54,700	New	+$1.04M	0.02%	476

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

FCMI

Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return

HBK Investments's INSM Position: Q3 2018 in Review

HBK Investments sold out of Insmed (INSM) in Q3 2018, closing a stake of 12,300 shares — an estimated $291K sold.

HBK Investments first reported a position in INSM in Q1 2014 and held it in 11 quarters. The position peaked at $2.88M in Q3 2017. 123 funds tracked by Wall St. Rank hold INSM as of Q3 2018.

HBK Investments reported no remaining Insmed position as of Q3 2018 after selling out during the quarter.
HBK Investments sold 12,300 Insmed shares in Q3 2018, an estimated $291K.
HBK Investments first reported a position in Insmed in Q1 2014 and held it in 11 quarters.
HBK Investments's Insmed position peaked at $2.88M in Q3 2017.
123 funds tracked by Wall St. Rank held Insmed as of Q3 2018.

Based on HBK Investments's 13F filing for Q3 2018, filed 14 Nov 2018.